Evidence map›Paper›PMID 40626311›Full record

ArticleFrontiers in pharmacology2025

Adverse drug reaction signal detection via the long short-term memory model.

Mengqi Cao, Yanna Chi, Jinyang Yu, Yu Yang, Ruogu Meng, Jinzhu Jia

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mengqi CaoDepartment of Biostatistics, School of Public Health, Peking University, Beijing, China.
Yanna ChiDepartment of Genetics, Peking University Cancer Hospital and Institute, Beijing, China.
Jinyang YuCenter for ADR Monitoring of Guangdong, Guangzhou, China.
Yu YangNational Institute of Health Data Science, Peking University, Beijing, China.
Ruogu MengNational Institute of Health Data Science, Peking University, Beijing, China.
Jinzhu JiaDepartment of Biostatistics, School of Public Health, Peking University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Drug safety has increasingly become a serious public health problem that threatens health and damages social economy. The common detection methods have the problem of high false positive rate. This study aims to introduce deep learning models into the adverse drug reaction (ADR) signal detection and compare different methods. Methods: The data are based on adverse events collected by Center for ADR Monitoring of Guangdong. Traditional statistical methods were used for data preliminary screening. We transformed data into free text, extracted text information and made classification prediction by using the Long Short-Term Memory (LSTM) model. We compared it with the existing signal detection methods, including Logistic Regression, Random Forest, K-NearestNeighbor, and Multilayer Perceptron. The feature importance of the included variables was analyzed. Results: A total of 2,376 ADR signals were identified between January 2018 and December 2019, comprising 448 positive signals and 1,928 negative signals. The sensitivity of the LSTM model based on free text reached 95.16%, and the F1-score was 0.9706. The sensitivity of Logistic Regression model based on feature variables was 86.83%, and the F1-score was 0.9063. The classification results of our model demonstrate superior sensitivity and F1-score compared to traditional methods. Several important variables "Reasons for taking medication", "Serious ADR scenario 4", "Adverse reaction analysis 5", and "Dosage" had an important influence on the result. Conclusion: The application of deep learning models shows potential to improve the detection performance in ADR monitoring.

Indexed as

adverse drug reactionfeature importancefree textsignal detectionthe long short-term memory model

Identifiers

PMID40626311
PMCPMC12230008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.